Advertisement
Home »

Cost-effectiveness of an insertable cardiac monitor in a high-risk population in the US.

Jan 30, 2023

ABOUT THE CONTRIBUTORS

  • Mitchell S V Elkind

    Department of Neurology, Vagelos College of Physicians and Surgeons, and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.

    Klaus K Witte

    Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.

    University Clinic, RWTH, Aachen, Germany.

    Scott E Kasner

    Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA.

    Laura M Sawyer

    Symmetron Limited, 8 Devonshire Square, London, EC2M 4PL, UK. lsawyer@symmetron.net.

    Frank W Grimsey Jones

    Symmetron Limited, 8 Devonshire Square, London, EC2M 4PL, UK.

    Claudia Rinciog

    Symmetron Limited, 8 Devonshire Square, London, EC2M 4PL, UK.

    Stelios Tsintzos

    Medtronic, Mounds View, MN, USA.

    Sarah C Rosemas

    Medtronic, Mounds View, MN, USA.

    David Lanctin

    Medtronic, Mounds View, MN, USA.

    Paul D Ziegler

    Medtronic, Mounds View, MN, USA.

    Matthew R Reynolds

    Baim Institute for Clinical Research, Boston, MA, USA.

    Lahey Hospital and Medical Center, Burlington, MA, USA.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement